Psychoeducational preventive treatment for women at risk of postpartum depression: study protocol for a randomized controlled trial, PROGEA
Ugarte Ugarte, Amaia
Serrulla Vangeneberg, Carmen
Torregaray Royo, Julia Gemma
Arrieta Ugarte, Maria Asunción
Zabalza Compains, Maria Teresa
Riaño Medrano, Maria Pilar
Muñoz Toyos, Nerea
Arenaza Lamo, Edurne
Beneitez Dueñas, Maria Begoña
González Pinto Arrillaga, Ana María
MetadataShow full item record
BMC Psichiatry 17 : (2017) // Article ID 13
Background: Postpartum depression is a disease with a prevalence of 20% that has deleterious consequences not only for the mother but also for the baby and can cause delays in physical, social and cognitive development. In this context, the European Union Committee on Public Health has declared it essential that preventative measures are taken by centres providing care for women with a multidisciplinary approach. PROGEA is a multicentre, single-blind randomized, 3-year, longitudinal clinical trial aiming to evaluate the efficacy of a psychoeducational programme in preventing postpartum depression in at-risk women, based on a range of clinical variables, and explore prognostic factors. This paper describes the methods and rationale behind the study. Methods: We will study women receiving treatment as usual plus a psychoeducation cognitive behavioural therapy (CBT)-based intervention and a control group receiving only treatment as usual. The sample will be recruited from an incidental sampling of pregnant women in two health regions. We will recruit 600 women in the third trimester of pregnancy who consent to take part in the study. Almost half of the women, about 280, would be expected to have some risk factors for postpartum depression. All those found to have risk factors will be evaluated, and we estimate that a quarter will be classified as at-risk of developing postpartum depression as measured with the Edinburgh Postnatal Depression Scale. This subset will be randomly allocated to receive treatment as usual with or without the CBT intervention. Six sessions of CBT (1 individual and 5 group) will be offered by a psychologist. Discussion: Findings from this study will be used to design a definitive study that will examine the clinical and cost-effectiveness of the CBT-based intervention in improving the mood of women in the postpartum period.
Except where otherwise noted, this item's license is described as This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Showing items related by title, author, creator and subject.
The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers Fernández Martínez, Manuel; Elcoroaristizabal Martín, Xabier; Galdos Alcelay, Luis; Castro Flores, Jessica; Uterga Valiente, Juan MarÍa; Indakoetxea Juanbeltz, Begoña; Gómez Beldarrain, María Angeles; Moraza López, Josefa; González Fernández, María Carmen; Molano Salazar, Ana; Bereincua Gandarias, Rocío; Inglés Borda, Sandra; Ortiz Marqués, Nuria; Barandiaran Amillano, Miryam; Carrasco Zabaleta, María; Martínez de Pancorbo Gómez, María de los Angeles (BioMed Central, 2009-09)Background: The aim of this study is to examine the influence of the catechol-O-methyltranferase (COMT) gene (polymorphism Val158 Met) as a risk factor for Alzheimer's disease (AD) and mild cognitive impairment of amnesic ...
Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery Jiménez Agüero, Raúl; Emparanza, José Ignacio; Beguiristain Gómez, Adolfo; Bujanda Fernández de Pierola, Luis; Alustiza Echeberria, José María; García, Elisabeth; Hijona Muruamendiaraz, Elizabeth; Gallego, Lander; Sanchez Gonzalez, Javier; Perugorria Montiel, María Jesús; Asensio, José I; Larburu Echaniz, Santiago; Garmendia Antin, Maddi; Larzabal, Mikel; Portillo Baquedano, María Puy; Aguirre López, Leixuri; Bañales Asurmendi, Jesús María (Biomed Central, 2014-08-26)Background: Non-alcoholic fatty liver disease (NAFLD) is caused by abnormal accumulation of lipids within liver cells. Its prevalence is increasing in developed countries in association with obesity, and it represents a ...
Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene Valcárcel Ocete, Leire; Alkorta Aranburu, Gorka; Iriondo Orensanz, Mikel; Fullaondo Elordui-Zapaterieche, Asier; García-Barcina, María; Fernández-García, José Manuel; Lezcano-García, Elena; Losada-Domingo, José María; Ruiz-Ojeda, Javier; Álvarez de Arcaya, Amaia; Pérez- Ramos, José María; Roos, Raymund A. C.; Nielsen, Jørgen E.; Saft, Carsten; REGISTRY investigators of the European Huntington's Disease Network; Zubiaga Elordieta, Ana María; Aguirre Escobal, Ana Isabel (Public Library Science, 2015-07-06)Age of onset (AO) of Huntington disease (HD) is mainly determined by the length of the CAG repeat expansion (CAGexp) in exon 1 of the HTT gene. Additional genetic variation has been suggested to contribute to AO, although ...